MedPath

Bismuth subcitrate potassium

Generic Name
Bismuth subcitrate potassium
Brand Names
Pylera
Drug Type
Small Molecule
Chemical Formula
C12H8BiK5O14
CAS Number
880149-29-1
Unique Ingredient Identifier
BQE6KE1T4H

Overview

A bismuth compound used for peptic ulcer and gastro-oesophageal reflux disease (GORD).

Background

A bismuth compound used for peptic ulcer and gastro-oesophageal reflux disease (GORD).

Indication

For the treatment of peptic ulcer and gastro-oesophageal reflux disease (GORD). Treatment of inflammatory and erosive-ulcerous diseases of gastric and duodenal mucosa: gastritis, ulcer disease of the stomach and duodenum, functional non-ulcerous dyspepsia, erosive duodenitis, post-operative inflammatory and erosive changes – anastomositis, peptic ulcer of anastomosis

Associated Conditions

  • Cough, Acute
  • Helicobacter Pylori Infection

Clinical Trials

Not Applicable
Terminated
Posted: 2019/04/24
Sponsor:
Università degli Stu...

FDA Approved Products

Pylera
Manufacturer:Allergan, Inc.
Route:ORAL
Strength:140 mg in 1 1
Approved: 2023/11/15
NDC:58914-601
Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride
Manufacturer:Ingenus Pharmaceuticals, LLC
Route:ORAL
Strength:140 mg in 1 1
Approved: 2023/07/04
NDC:50742-283
BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE
Manufacturer:H2-Pharma, LLC
Route:ORAL
Strength:140 mg in 1 1
Approved: 2023/05/31
NDC:61269-385
Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride
Manufacturer:Par Pharmaceutical, Inc.
Route:ORAL
Strength:140 mg in 1 1
Approved: 2023/03/15
NDC:49884-151
Pylera
Manufacturer:Physicians Total Care, Inc.
Route:ORAL
Strength:140 mg in 1 1
Approved: 2011/03/14
NDC:54868-6151

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath